Neil Rudd is the current Chief Financial Officer at Palm Therapeutics. Neil has previously served as the Chief Operating Officer at NXT Capital from August 2019 to January 2021, the Chief Financial and Administrative Officer at NXT Capital from January 2010 to August 2019, and Managing Director - Chief Operating Officer at Merrill Lynch Capital from November 2001 to February 2008. Prior to that, they were the Senior Vice President of Strategy and Corporate Development at Heller Financial from January 1990 to December 2001. Neil Rudd began their professional career as a Staff Auditor at Price Waterhouse from July 1987 to April 1990.
Neil Rudd has a Master of Business Administration (MBA) from Northwestern University - Kellogg School of Management in Finance and Marketing and a B.A. in Accounting from the University of Northern Iowa.
Neil Rudd works with and Neal Devaraj - Scientific Co-Founder. Neil Rudd reports to Andrew Rudd, Co-Founder & CEO.
Current role